Evidence map›Paper›PMID 31735951›Full record

ReviewDatabase : the journal of biological databases and curation2019

Representing glycophenotypes: semantic unification of glycobiology resources for disease discovery.

Jean-Philippe F Gourdine, Matthew H Brush, Nicole A Vasilevsky, Kent Shefchek, Sebastian Köhler, Nicolas Matentzoglu, Monica C Munoz-Torres, Julie A McMurry, Xingmin Aaron Zhang, Peter N Robinson and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Database : the journal of biological databases and curation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. The Human Phenotype Ontology in 2021.Nucleic acids research · 2021
    Article
  5. Article
  6. Article
  7. Three-Dimensional Structures of Carbohydrates and Where to Find Them.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Jean-Philippe F GourdineOregon Clinical & Translational Research Institute, Oregon Health & Science University, Portland, OR 97239, USA.
Matthew H BrushOregon Clinical & Translational Research Institute, Oregon Health & Science University, Portland, OR 97239, USA.
Nicole A VasilevskyOregon Clinical & Translational Research Institute, Oregon Health & Science University, Portland, OR 97239, USA.
Kent ShefchekMonarch Initiative, monarchinitiative.org.
Sebastian KöhlerMonarch Initiative, monarchinitiative.org.
Nicolas MatentzogluMonarch Initiative, monarchinitiative.org.
Monica C Munoz-TorresMonarch Initiative, monarchinitiative.org.
Julie A McMurryMonarch Initiative, monarchinitiative.org.
Xingmin Aaron ZhangMonarch Initiative, monarchinitiative.org.
Peter N RobinsonMonarch Initiative, monarchinitiative.org.
Melissa A HaendelOregon Clinical & Translational Research Institute, Oregon Health & Science University, Portland, OR 97239, USA.
Oregon Clinic · USOregon State University · USJackson Laboratory · USCharité - Universitätsmedizin Berlin · DEEuropean Bioinformatics Institute · GBOregon Health & Science University · US

Funding

U2C Kids First Admin Supplement - data transferU2CHL138346 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI HEATH, ALLISON · 2017 to 2022
$21.5M
The Monarch Initiative: Linking Diseases to Model Organism ResourcesR24OD011883 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAENDEL, MELISSA A, MUNGALL, CHRISTOPHER J · 2012 to 2024
$16.0M
Undiagnosed Diseases Network Metabolomics Core SupplementU01TR001395 · NCATS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI KOELLER, DAVID M, METZ, THOMAS O · 2015 to 2018
$2.3M
NCATS NIH HHS U01 TR001395NHLBI NIH HHS U2C HL138346NIH HHS R24 OD011883
6 · The paper itself

Abstract

While abnormalities related to carbohydrates (glycans) are frequent for patients with rare and undiagnosed diseases as well as in many common diseases, these glycan-related phenotypes (glycophenotypes) are not well represented in knowledge bases (KBs). If glycan-related diseases were more robustly represented and curated with glycophenotypes, these could be used for molecular phenotyping to help to realize the goals of precision medicine. Diagnosis of rare diseases by computational cross-species comparison of genotype-phenotype data has been facilitated by leveraging ontological representations of clinical phenotypes, using Human Phenotype Ontology (HPO), and model organism ontologies such as Mammalian Phenotype Ontology (MP) in the context of the Monarch Initiative. In this article, we discuss the importance and complexity of glycobiology and review the structure of glycan-related content from existing KBs and biological ontologies. We show how semantically structuring knowledge about the annotation of glycophenotypes could enhance disease diagnosis, and propose a solution to integrate glycophenotypes and related diseases into the Unified Phenotype Ontology (uPheno), HPO, Monarch and other KBs. We encourage the community to practice good identifier hygiene for glycans in support of semantic analysis, and clinicians to add glycomics to their diagnostic analyses of rare diseases.

Indexed as

DiseaseGlycomicsSemanticsAnimalsHumansKnowledge BasesPhenotypePolysaccharidesPolysaccharides

Identifiers

PMID31735951
PMCPMC6859258
OpenAlexW2951325282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.